Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sinead A. Noonan"'
Autor:
David O’Reilly, Ronan McLaughlin, Cian Ronayne, Anne Marie De Frein, Bojan Macanovic, Ryan W. Chu, Sinead A. Noonan, Roisin M. Connolly, Derek G. Power, Richard M. Bambury, Seamus O’Reilly, Dearbhaile Catherine Collins
Publikováno v:
Irish Journal of Medical Science (1971 -). 192:541-548
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba3ad8c7553bf33e7e1baabb06561128
https://doi.org/10.1007/s11845-022-02990-3
https://doi.org/10.1007/s11845-022-02990-3
Autor:
David, O'Reilly, Ronan, McLaughlin, Cian, Ronayne, Anne Marie, De Frein, Bojan, Macanovic, Ryan W, Chu, Sinead A, Noonan, Roisin M, Connolly, Derek G, Power, Richard M, Bambury, Seamus, O'Reilly, Dearbhaile Catherine, Collins
Publikováno v:
Irish journal of medical science.
There are disparities in the availability of systemic anticancer therapies (SACTs) globally. We set out to investigate the cost and reimbursement of SACTs in the United Kingdom (UK) and the Republic of Ireland (ROI) in conjunction with efficacy and l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17a5b53b90537e003312565c18fa951e
https://pubmed.ncbi.nlm.nih.gov/35449390
https://pubmed.ncbi.nlm.nih.gov/35449390
Autor:
Yoko Korenaga Fukuda, Jeffrey W. Clark, Shirish M. Gadgeel, Pasi A. Jänne, Patrick M. Forde, Giulia Costanza Leonardi, Sasha Kravets, Viola W. Zhu, Daniel B. Costa, Lynette M. Sholl, Sai-Hong Ignatius Ou, D. Ross Camidge, Rebecca S. Heist, Suzanne E. Dahlberg, Tony Mok, Alexander Drilon, Mark M. Awad, Sinead A. Noonan, Conor E. Steuer
Publikováno v:
Lung Cancer
Objectives Although dramatic responses to MET inhibitors have been reported in patients with MET exon 14 (METex14) mutant non-small cell lung cancer (NSCLC), the impact of these treatments on overall survival in this population is unknown. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3357303dbbdb142ce4f034ce38f5ec63
https://pubmed.ncbi.nlm.nih.gov/31200835
https://pubmed.ncbi.nlm.nih.gov/31200835
Autor:
William T. Purcell, Paul A. Bunn, Sinead A. Noonan, Laurie L. Carr, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner, Tejas Patil
Publikováno v:
Lung Cancer. 96:27-32
Introduction Peritoneal metastasis from lung cancer is an uncommon clinical event and there are limited data on what factors predict peritoneal progression. This study retrospectively investigated whether patterns of metastatic spread and oncogene st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df4c1f9e08d285b376a847673d5303b2
https://doi.org/10.1016/j.lungcan.2016.03.007
https://doi.org/10.1016/j.lungcan.2016.03.007
Autor:
Anna E. Barón, D. Ross Camidge, Dexiang Gao, Xian Lu, Jessica R. Thibault, Robert C. Doebele, Paul A. Bunn, Gentry G. King, Sinead A. Noonan, W. Thomas Purcell, Tejas Patil
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(1)
Introduction The role of serum tumor markers in the modern management of advanced NSCLC remains poorly described. Methods A single-center retrospective analysis of available carcinoembryonic antigen, CA125, CA19.9, and CA27.29 levels at baseline and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75124dccf0483350d7e78caebdf2e21
https://pubmed.ncbi.nlm.nih.gov/28843358
https://pubmed.ncbi.nlm.nih.gov/28843358
Autor:
Anna E. Barón, Dara L. Aisner, Jamie Sheren, Marileila Varella-Garcia, Patrick C. Chesnut, Sinead A. Noonan, Lynne D. Berry, Robert C. Doebele, Daniel T. Merrick, Dexiang Gao, Xian Lu, D. Ross Camidge
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(8)
Mesenchymal-epithelial transition factor gene (MET) gene copy number gain may be a predictive biomarker for mesenchymal-epithelial transition factor (MET) inhibition in lung cancer, but the most appropriate method and criteria for defining MET positi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979f4677460ca201cc493334933f46f5
https://pubmed.ncbi.nlm.nih.gov/27262212
https://pubmed.ncbi.nlm.nih.gov/27262212
Autor:
Sinead A, Noonan, D Ross, Camidge
Publikováno v:
Translational lung cancer research. 4(5)
PROFILE 1014 compared crizotinib to up to six cycles of standard platinum-pemetrexed chemotherapy as the first line treatment of advanced anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). Overall, PROFILE 1014 has taught
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67b93a5d9183ce081aa0d8dfecc4c8d9
https://pubmed.ncbi.nlm.nih.gov/26629438
https://pubmed.ncbi.nlm.nih.gov/26629438
Autor:
Sinead A. Noonan, Jeffrey W. Clark, Conor E. Steuer, Lynette M. Sholl, Sai-Hong Ignatius Ou, Daniel B. Costa, Viola W. Zhu, Alexander Drilon, Suzanne E. Dahlberg, Tony Mok, Sasha Kravets, D. Ross Camidge, Yoko Korenaga Fukuda, Shirish M. Gadgeel, Patrick M. Forde, Giulia Costanza Leonardi, Mark M. Awad, Pasi A. Jänne, Rebecca S. Heist
Publikováno v:
Journal of Clinical Oncology. 35:8511-8511
8511 Background: Dramatic responses to MET inhibitors have been reported in patients with NSCLC harboring activating mutations that cause MET exon 14 ( METdel14) skipping. We conducted a multicenter retrospective analysis of pts with METdel14 NSCLC t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c84fec86621a2fa081a77efc364d3373
https://doi.org/10.1200/jco.2017.35.15_suppl.8511
https://doi.org/10.1200/jco.2017.35.15_suppl.8511